Can Creatine Damage Your Liver? What the Research Says

Creatine monohydrate, one of the most studied sports supplements on the planet, does not appear to damage the liver in healthy people at standard doses. Population-level data and long-term monitoring studies consistently show no meaningful increase in liver enzyme markers among creatine users. The concern persists partly because of a single dramatic case report that circulates widely, partly because creatine can change blood markers in ways that look alarming if your doctor doesn’t know you’re taking it, and partly because animal research paints a more complicated picture when alcohol or physical inactivity enters the equation.

What Population-Level Data Actually Show

The most reassuring evidence comes from a large cross-sectional analysis using data from the U.S. National Health and Nutrition Examination Survey (NHANES), which looked at creatine consumption and liver disease markers in people aged 12 and older. After adjusting for confounding variables, the researchers found no significant association between creatine intake and albumin, ALT, AST, GGT, or total bilirubin, all standard markers clinicians use to evaluate liver health.¹ The only markers that showed a statistically significant relationship were alkaline phosphatase (which went down with higher creatine intake) and the AST-to-ALT ratio (also lower). Neither of those changes points toward liver harm; if anything, a lower AST-to-ALT ratio is generally considered favorable.

Separate monitoring of competitive team-sport athletes who used creatine over extended periods told a similar story. Blood concentrations of clinical parameters didn’t change significantly across the supplementation period. Creatinine and creatine kinase were elevated, which is expected because those are direct products of creatine metabolism and muscle activity, but the rest of the panel stayed within normal clinical ranges.² This distinction between creatinine (a breakdown product of creatine that naturally rises when you take more creatine) and true liver enzymes is critical, and it’s the source of a lot of unnecessary worry.

The Case Report That Fuels the Fear

If you search the medical literature for “creatine liver damage,” the most alarming result is a published case of a 27-year-old weightlifter who developed acute cholestatic liver injury. He had been taking creatine for about eight or nine months and whey protein for four weeks before developing painless jaundice. His total bilirubin shot up to 54.7 mg/dL, dramatically above normal, and his alkaline phosphatase hit 436 U/L. Viral hepatitis, autoimmune disease, and Wilson’s disease were all ruled out. A liver biopsy confirmed cholestasis with ductular proliferation. He recovered after stopping the supplements and receiving IV fluids.³

This case gets cited frequently, but it has some significant limitations as evidence against creatine specifically. The patient was taking both creatine and whey protein, so it’s impossible to pin the injury on one supplement or the other, or on some interaction between the two. The paper itself describes the injury as associated with the combination of supplements. It’s also a single case report, which sits at the very bottom of the evidence hierarchy. A single person developing an idiosyncratic reaction doesn’t tell us much about what happens in the general population, especially when thousands of people have been monitored in controlled settings without similar events. Idiosyncratic drug and supplement reactions happen with substances that are broadly considered safe, from acetaminophen to green tea extract. The case is worth knowing about, but treating it as proof that creatine damages the liver stretches it well beyond what the evidence can support.

Why Your Blood Work Can Look Wrong

A more common and more practical problem is that creatine use, particularly when combined with regular exercise, can produce blood test results that trigger unnecessary alarm. Creatine is broken down into creatinine, which the kidneys filter out. When you supplement with creatine, your serum creatinine rises. This is not because your kidneys are struggling; it’s simply because there is more creatinine to clear. But creatinine is a routine marker on metabolic panels, and an unexpectedly high reading can prompt a cascade of follow-up testing if your doctor doesn’t know you supplement.

The liver side of this problem is even more commonly misunderstood. A published case study highlighted how a healthy adult male who exercised regularly presented with an abnormal liver panel, meaning elevated AST and ALT. The workup went through the standard diagnostic pathway for liver disease. The problem? AST and ALT aren’t exclusive to the liver. They’re also released from muscle tissue during intense exercise. The diagnostic pathway in that case didn’t include any assessment of muscle biomarkers like creatine kinase, or any inquiry into the patient’s exercise habits.⁴ The authors flagged this as a knowledge gap in primary care, and it genuinely is. If you lift weights and take creatine, your AST, ALT, creatine kinase, and creatinine can all run above the standard reference ranges without anything being wrong. Tell your doctor about your supplement use and exercise routine before blood draws. Ideally, avoid heavy training for 48 to 72 hours before labs to get a cleaner picture.

The Animal Research Complicates Things

While human data are reassuring, animal studies introduce some nuance that’s worth understanding. A study in rats used high-dose creatine supplementation and tracked liver and kidney outcomes in both sedentary and exercised groups. By eight weeks, the sedentary rats receiving creatine had significantly elevated liver enzymes, including ALT, AST, GGT, and alkaline phosphatase, and showed structural changes suggesting hepatic damage. But here’s the interesting part: the exercised rats taking the same doses did not show these changes.⁵ The authors concluded that long-term creatine supplementation may adversely affect the liver and kidneys of sedentary animals but not those who are physically active.

The doses used in these rat studies are far higher per kilogram of body weight than what any human would take, so direct translation to people is unreliable. But the pattern is noteworthy: exercise appears to offer a protective effect, and taking creatine while being completely sedentary might carry different risks than taking it as part of an active lifestyle. Most people who buy creatine are exercising, which makes the exercised-rat outcomes the more relevant comparison, but if you’re supplementing during a long period of inactivity (recovering from an injury, for instance), the animal data suggest some caution.

Creatine and Alcohol Are a Bad Combination

One area where the research does raise a genuine red flag involves alcohol. A study in mice found that creatine supplementation actually protected against diet-induced non-alcoholic fatty liver disease, reducing fat accumulation and liver damage in that context. But when the same researchers tested creatine alongside chronic alcohol exposure, the combination made things worse, not better.⁶

A separate mouse study confirmed this pattern. Ethanol intake on its own caused mild liver cell degeneration, oxidative damage, and inflammation. But ethanol combined with creatine worsened all of those outcomes, increasing fat accumulation, amplifying oxidative stress, boosting inflammatory gene expression, and raising plasma ALT, a direct marker of liver cell injury.⁷ These are animal studies, and we don’t have controlled human trials testing creatine plus alcohol on the liver. Still, the consistency of the finding across multiple experiments suggests that heavy or chronic drinking while supplementing with creatine is not a smart combination. If you drink regularly and use creatine, this is worth keeping in mind.

When Creatine Might Actually Protect the Liver

Perhaps the most surprising line of evidence runs in the opposite direction from the worry that prompted this question. Several research groups have found that creatine supplementation may reduce fat accumulation in the liver and slow the progression of metabolic-associated fatty liver disease (MAFLD), formerly known as non-alcoholic fatty liver disease.

Early animal work established that creatine prevents fat buildup in the livers of rats fed high-fat or choline-deficient diets, and similar effects were seen in liver cancer cells in vitro.⁸ A more recent review of preclinical evidence went further, concluding that creatine showed protective effects across multiple stages of fatty liver disease, from simple fat accumulation to inflammation and fibrosis, and worked in part by regulating lipid metabolism across multiple organs including adipose tissue.⁹

The mechanism behind this protective effect was initially thought to involve sparing a compound called S-adenosylmethionine (AdoMet) for other liver processes. The liver uses a large proportion of its methyl groups to synthesize creatine, so the theory was that supplementing creatine externally would free up those resources. Research confirmed that dietary creatine prevented fat accumulation and preserved AdoMet levels in rats on high-fat diets, but the protective mechanism turned out to be more about stimulating fatty acid oxidation than about methylation sparing. The hypothesis was partially right in predicting the outcome but wrong about the pathway, which is how science goes sometimes.

All of this research remains preclinical, meaning it’s been done in animals and cell cultures rather than in human clinical trials for fatty liver disease. But the direction of the findings is consistent and encouraging. It’s the kind of evidence that makes researchers consider creatine as a therapeutic tool for liver disease rather than a cause of it.

Pre-existing Liver Disease and the Evidence Gap

If you already have chronic liver disease, the picture gets murkier for a simple reason: almost no one has studied creatine supplementation in human patients with existing liver conditions. A review looking at creatine’s potential role in improving sarcopenia (the muscle wasting that often accompanies advanced liver disease) noted that while animal models of fatty liver suggest beneficial effects, and creatine shows promise for reducing encephalopathy and fatigue, the evidence in actual human patients with chronic liver disease is essentially absent.¹⁰

This creates an awkward gap. Creatine might help people with liver disease, particularly those losing muscle mass, and the animal data suggest it’s protective in non-alcoholic contexts. But without human trials specifically enrolling patients with impaired liver function, no one can confidently recommend it for that population. If you have a diagnosed liver condition, this is a conversation to have with your hepatologist rather than something to figure out from supplement forums.

Not All Creatine Formulations Are the Same

Creatine monohydrate is the form used in the vast majority of safety research, and it’s the form that has the strongest track record. Other formulations exist, and they don’t all behave the same way in the body. Creatine ethyl ester (CEE), marketed as a more bioavailable alternative, has a specific problem: it degrades to creatinine in stomach acid much more readily than monohydrate does. In a study comparing creatine ethyl ester to standard creatine monohydrate and placebo, the CEE group saw serum creatinine levels jump about threefold after the loading phase, and those levels stayed elevated above normal values throughout the study. The monohydrate group saw a modest increase that remained within the normal clinical range of 0.8 to 1.3 mg/dL.¹¹

This matters for two reasons. First, if you’re using creatine ethyl ester, your blood work is more likely to show abnormally high creatinine, which could trigger unnecessary alarm or a misdiagnosis of kidney problems. Second, the elevated creatinine means much of the supplement is being wasted as a metabolic byproduct rather than being taken up by muscles. The kidneys then have to filter all that extra creatinine. Creatine monohydrate remains the gold standard both for efficacy and for the clean safety profile established in the literature.

Supplement Purity and Hidden Risks

One often overlooked factor in supplement safety is the quality of the product itself. An analysis of 33 creatine supplement samples found that creatinine was the most common organic contaminant, present above 100 mg/kg in 44% of samples. About 15% of products contained dihydro-1,3,5-triazine above the detection limit, and a similar proportion had dicyandiamide concentrations over 50 mg/kg. Heavy metal testing found detectable levels of mercury, though below 1 mg/kg.¹²

Dihydrotriazine and dicyandiamide are byproducts of the manufacturing process for creatine, and their presence at elevated levels signals sloppy production rather than an inherent property of creatine itself. When someone takes a contaminated supplement for months and develops liver problems, it’s reasonable to ask whether the creatine or the impurities are to blame. This is a strong argument for buying from brands that use well-characterized creatine monohydrate, ideally with third-party testing or certificates of analysis. Creapure, a branded form manufactured in Germany, is the most commonly cited example of a high-purity source, though other tested products exist. The cheapest option from an unknown supplier carries risks that have nothing to do with creatine’s inherent safety profile.

Practical Considerations for Creatine Users

Pulling together what the research actually says, a few practical points emerge for people who use or are considering creatine:

Inform your doctor: Before any blood work, tell your healthcare provider that you take creatine and how often you exercise. This prevents misinterpretation of elevated creatinine, AST, or ALT as signs of liver or kidney disease.
Stick to monohydrate: The safety data overwhelmingly apply to creatine monohydrate. Ethyl ester and other novel formulations don’t have the same evidence base and can produce misleading blood markers.
Watch alcohol intake: Animal data consistently show that creatine worsens alcohol-related liver damage. While we lack human confirmation, the signal is strong enough to warrant caution with heavy or frequent drinking.
Use it with exercise: The one animal study that found liver harm in creatine-supplemented rats only found it in the sedentary group. If you’re supplementing but not training, you may be exposing yourself to a risk that doesn’t exist for active users.
Buy quality products: Manufacturing contaminants are a real issue. Third-party-tested creatine monohydrate from reputable sources reduces the chance that impurities, not creatine, cause problems.

People with pre-existing liver conditions occupy a genuinely uncertain space. The animal evidence leans protective, especially for fatty liver that isn’t alcohol-related, but the absence of human trials in liver disease patients means no responsible recommendation can be made without medical supervision. Anyone in that category should treat creatine as an open question to discuss with their specialist, not as something clearly safe or clearly dangerous.